Group 6E: Breast & Pan-Cancers; Leptomeningeal Disease; Clinical Trials

Thursday, June 15 6:00 pm – 7:30 pm Eastern Time (US/New York)

Mentor: Joan Mancuso

Joan Mancuso has been living with metastatic breast cancer since 2007. She was diagnosed with early stage breast cancer in 2003. For over a decade Joan has been involved in many breast cancer projects. She was an advocate member of the Translational Breast Cancer Research Consortium with Abramson Cancer Center, University of Pennsylvania. The TBCRC conducts high-impact clinical trials. Joan was also a member of the planning committee for the Metastatic Breast Cancer Research Conference’s annual meeting, working to develop the meeting’s advocate program. Through SHARE Cancer Support Joan was interviewed on talk radio to raise awareness of MBC during Breast Cancer Awareness Month. She facilitated a SHARE telephone support group for people living with MBC and wrote news stories about cancer conference sessions for an MBC newsletter, among many other projects over the years. Joan also participated as an advocate in the AACR’s Scientist<->Survivor Program. Joan is currently a volunteer in ASCO’s TAPUR Publications Group. She contributed to the section on patient education and access to the 2023 ASCO update on the use of biosimilars in oncology, published in JCO Oncology Practice. Joan was a consumer reviewer for the DOD Breast Cancer Research Program for several years and an advocate on scientific grant proposals and clinical trial protocols at major cancer centers. She is a former special reports editor on a news desk for financial news.

Twitter: @2020VisionGirl

Scientist: Laura Huppert, M.D.

Dr. Laura Huppert is an Assistant Professor and breast medical oncologist at the University of California, San Francisco (UCSF). Dr. Huppert earned her medical degree at Harvard Medical School. She completed Internal Medicine residency and Hematology/Oncology Fellowship at UCSF before starting on faculty at UCSF in July 2022. Dr. Huppert is interested in clinical and translational breast cancer research in both early-stage and metastatic disease. She is involved in the I-SPY2 clinical trial for neoadjuvant therapy in early-stage breast cancer. She is also interested in designing clinical trials with novel therapies for patients with metastatic breast cancer and is the PI of several investigator-initiated clinical trials with novel agents. She also has a particular interest in breast cancer that has metastasized to the central nervous system, and conducts translational research in this space aimed to better identify prevention and treatment strategies.

Twitter: @laura_huppert